The future of pelvic lymph node dissection for urological malignancies

Herr, H. W. et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J. Clin. Oncol. 22, 2781–2789 (2004).

Article  Google Scholar 

Washington, S. L. III, Carroll, P. R. & Porten, S. P. in Cancer Metastasis Through the Lymphovascular System (eds Leong, S. P., Nathanson, S. D. & Zager, J. S.) 587–592 (Springer, 2022).

Voskuilen, C. S. et al. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma. Eur. Urol. Oncol. 3, 73–79 (2020).

Article  Google Scholar 

Nguyen, D. P. et al. A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection. Eur. Urol. 70, 734–737 (2016).

Article  Google Scholar 

Schilham, M. G. M. et al. Head-to-head comparison of 68Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10-enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients. J. Nucl. Med. 62, 1258–1263 (2021).

CAS  Article  Google Scholar 

Suarez-Ibarrola, R. et al. Is there an oncological benefit of performing bilateral pelvic lymph node dissection in patients with penile cancer and inguinal lymph node metastasis? J. Clin. Med. 10, 754 (2021).

Article  Google Scholar 

Seisen, T. et al. Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma. World J. Urol. 35, 535–548 (2017).

CAS  Article  Google Scholar 

Gschwend, J. E. et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. Eur. Urol. 75, 604–611 (2019).

Article  Google Scholar 

Lestingi, J. F. P. et al. Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial. Eur. Urol. 79, 595–604 (2021).

Article  Google Scholar 

留言 (0)

沒有登入
gif